Hepatitis C Virus (HCV) is a hepatotropic virus, ~80 million chronic infections being confirmed worldwide. HCV infection leads to the development of chronic hepatitis, cirrhosis, and in some instances, hepatocellular carcinoma. The recent development of highly potent direct-acting antiviral drugs (DAAs), targeting viral proteins, facilitates virus elimination in >90% of treated individuals. However, the mechanism of DAA failure in the remaining 10% is not understood.
The liver is a vital organ with functions in the metabolism of carbohydrates, proteins, and lipids, the clearance of toxins and pathogens, and the regulation of immune reactions. Previously, the present research group discovered selenoprotein P (SeP), a liver-derived secretory protein contributes to the induction of insulin resistance and is involved in the pathogenesis of type 2 diabetes. Interestingly, patients with both chronic hepatitis C (CHC) and type 2 diabetes are reported to show a tendency to be unresponsive to DAAs. In the present study, the group investigated the pathogenic and clinical relationship of HCV infection and type 2 diabetes, focusing on SeP.
The group investigated the effects of SeP on antiviral immune responses in the liver, using cultured cells, mice and clinical specimens. It was found that HCV infection augmented SeP expression in cultured cells. By analyzing clinical specimens, it was found that serum SeP levels were higher in HCV-infected patients than healthy controls and that treatment with DAAs was less effective in patients with higher levels of SeP expression.
On the other hand, a remarkable repression of HCV replication was observed in the cultured cells with suppressed expression of SeP. These cells were also found to have an augmented production of interferon (IFN), which has antiviral activity. Humans are known to have a system to detect virus invasion into cells and to induce IFN production. It is reported that RIG-I) and MDA5 (melanoma differentiation-associated gene 5) recognize virus-derived RNA and induce IFN production. Although RIG-I and MDA5 have a highly homologous helicase domain), they recognize different RNAs depending upon RNA structure as well as base alignment (PAMP: pathogen-associated molecular pattern). HCV is thought to be recognizable by both RIG-I and MDA5. By performing experiments using a RIG-I knockout cell line and a MDA5 knockout cell line, SeP was found to specifically regulate RIG-I pathway-dependent innate immune responses.
In more detailed experiments using purified SeP and synthetic RNA, repression of innate immunity by SeP was shown to be brought about not by the protein but by the SeP mRNA. Upon binding of a viral RNA to RIG-I, the ATPase activity of RIG-I is stimulated to induce a three-demensional structural change and oligomerization of RIG-I, which binds to mitochondrial antiviral signaling protein to activate IFN production. It was found that overexpression of SeP mRNA inhibited the ATPase activity important in the RIG-I activation steps: oligomerization of RIG-I and RIG-I localization to mitochondria. SeP mRNA, by binding to and interacting with the regulatory domain (RD) of RIG-I protein that specifically recognizes and captures viral RNA, inhibited the three-dimensional structural change necessary for RIG-I activation, and negatively regulated innate immunity.
Thus the present study has elucidated the regulation mechanism of innate immunity by SeP mRNA via RIG-I, one of the antiviral immune regulation mechanisms in the liver.
https://www.kanazawa-u.ac.jp/latest-research/66452
https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(19)30111-8
Viral infection induces host mRNA to protect against antiviral response
- 2,224 views
- Added
Edited
Latest News
TB blood test which could d…
By newseditor
Posted 27 Mar
Propionate supplementation…
By newseditor
Posted 27 Mar
Role of human Kallistatin i…
By newseditor
Posted 26 Mar
Addressing both flu and COV…
By newseditor
Posted 26 Mar
How the brain senses body p…
By newseditor
Posted 26 Mar
Other Top Stories
Omega-3 may block psychosis years later
Read more
A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerat…
Read more
Sleep apnea and brain damage
Read more
PTSD could be prevented by blocking memory consolidation pathway!
Read more
Body fat hormone leptin influences runner's high
Read more
Protocols
All-optical presynaptic pla…
By newseditor
Posted 23 Mar
Epigenomic tomography for p…
By newseditor
Posted 20 Mar
A mouse DRG genetic toolkit…
By newseditor
Posted 17 Mar
An optogenetic method for t…
By newseditor
Posted 13 Mar
Profiling native pulmonary…
By newseditor
Posted 08 Mar
Publications
Integrated plasma proteomic…
By newseditor
Posted 27 Mar
APP antisense oligonucleoti…
By newseditor
Posted 27 Mar
Targeting Erbin-mitochondri…
By newseditor
Posted 27 Mar
Regulation of Zbp1 by miR-9…
By newseditor
Posted 27 Mar
Pain-free oral delivery of…
By newseditor
Posted 27 Mar
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar